4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

The present document has been conceived as the European update to the American
College of Cardiology (ACC)/American Heart Association (AHA)/ESC 2006 Guidelines for …

A unique and highly versatile technique, stress echocardiography (SE) is increasingly
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …

Arrhythmogenic cardiomyopathy is an inherited heart muscle disorder, predisposing to
sudden cardiac death, particularly in young patients and athletes. Pathological features …

Ventricular arrhythmias are an important cause of morbidity and mortality and come in a
variety of forms, from single premature ventricular complexes to sustained ventricular …

442 Circulation August 4, 2015 largely composed of patients referred because of their
highrisk status or severe clinical manifestations requiring specialized therapeutic …

Background: Accurate and expedited identification of scar regions most prone to reentry is
needed to guide ventricular tachycardia (VT) ablation. We aimed to prospectively assess …

Although implantable cardioverter-defibrillators positively affect survival in patients at
increased risk for arrhythmic sudden cardiac death, quality of life can be negatively affected …